Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Quality of Life Research 3/2021

23-09-2020

A head-to-head comparison of measurement properties of the EQ-5D-3L and EQ-5D-5L in acute myeloid leukemia patients

Auteurs: Hongjuan Yu, Xueyun Zeng, Mingjie Sui, Rui Liu, Rachel Lee-Yin Tan, Jinjin Yang, Weidong Huang, Nan Luo

Gepubliceerd in: Quality of Life Research | Uitgave 3/2021

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

This study aimed to compare the measurement properties of EQ-5D-3L(3L) and EQ-5D-5L(5L) in patients with acute myeloid leukemia (AML) in China.

Methods

We consecutively recruited 168 patients with AML from three tertiary hospitals to complete two rounds of interviews using the two versions of the EQ-5D. We compared (i) the ceiling effect using the McNemar’s test, (ii) test–retest reliability using intraclass correlation coefficient (ICC) and Cohen’s weighted Kappa, (iii) convergent validity using Spearman’s rank correlation coefficient (r) and iv) discriminatory ability using F statistic and area under the receiver operating characteristics curve (AUROC) of the 5L and the 3L.

Results

The 5L descriptive system showed significantly lower ceiling effects in comparison to the 3L descriptive system (p < 0.001). While 5L showed superior reproducibility (Cohen’s weighted Kappa = 0.56–0.67 and ICC = 0.89), both instruments exhibited good test–retest reliability. Even though both 3L and 5L showed good convergent and known-groups validity, 5L showed better convergent validity and discriminatory ability.

Conclusion

The current study found both 3L and 5L to be suitable for use in AML patients. However, 5L showed superior measurement properties compared to 3L. Thus, 5L could be the preferred instrument over 3L for use in AML patients.

Met onderstaand(e) abonnement(en) heeft u direct toegang:

BSL Podotherapeut Totaal

Binnen de bundel kunt u gebruik maken van boeken, tijdschriften, e-learnings, web-tv's en uitlegvideo's. BSL Podotherapeut Totaal is overal toegankelijk; via uw PC, tablet of smartphone.

Literatuur
1.
go back to reference Devlin, N. J., & Brooks, R. (2017 Apr). EQ-5D and the EuroQol group: past, present and future. Applied Health Economics and Health Policy, 15(2), 127–137. CrossRef Devlin, N. J., & Brooks, R. (2017 Apr). EQ-5D and the EuroQol group: past, present and future. Applied Health Economics and Health Policy, 15(2), 127–137. CrossRef
2.
go back to reference Brooks, R. J. (1996). EuroQol: the current state of play. Healthy Policy, 37(1), 53–72. CrossRef Brooks, R. J. (1996). EuroQol: the current state of play. Healthy Policy, 37(1), 53–72. CrossRef
3.
go back to reference Group TE. (1990). EuroQol—a new facility for the measurement of health-related quality of life. Health Policy, 36, 199–208. Group TE. (1990). EuroQol—a new facility for the measurement of health-related quality of life. Health Policy, 36, 199–208.
6.
go back to reference Pattanaphesaj, J., & Thavorncharoensap, M. J. H. (2015). Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients. Health and Quality of Life Outcomes, 13(1), 14. CrossRef Pattanaphesaj, J., & Thavorncharoensap, M. J. H. (2015). Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients. Health and Quality of Life Outcomes, 13(1), 14. CrossRef
7.
go back to reference Scalone, L., Ciampichini, R., Fagiuoli, S., Gardini, I., Fusco, F., Gaeta, L., et al. (2013). Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases. Quality of Life Research, 22(7), 1707–1716. CrossRef Scalone, L., Ciampichini, R., Fagiuoli, S., Gardini, I., Fusco, F., Gaeta, L., et al. (2013). Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases. Quality of Life Research, 22(7), 1707–1716. CrossRef
8.
go back to reference Golicki, D., Niewada, M., Karlińska, A., Buczek, J., Kobayashi, A., Janssen, M. F., et al. (2014). Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients. Quality of Life Research, 24(6), 1555–1263. CrossRef Golicki, D., Niewada, M., Karlińska, A., Buczek, J., Kobayashi, A., Janssen, M. F., et al. (2014). Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients. Quality of Life Research, 24(6), 1555–1263. CrossRef
9.
go back to reference Poór, A. K., Rencz, F., Brodszky, V., Gulácsi, L., Beretzky, Z., Hidvégi, B., et al. (2016). Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients. Value in Health, 19(7), A572–A573. CrossRef Poór, A. K., Rencz, F., Brodszky, V., Gulácsi, L., Beretzky, Z., Hidvégi, B., et al. (2016). Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients. Value in Health, 19(7), A572–A573. CrossRef
10.
go back to reference Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., et al. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20(10), 1727–1236. CrossRef Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., et al. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20(10), 1727–1236. CrossRef
11.
go back to reference Pickard, A. S., De Leon, M. C., Kohlmann, T., Cella, D., & Sarah, M. C. (2007). Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Rosenbloom, 45(3), 259–263. Pickard, A. S., De Leon, M. C., Kohlmann, T., Cella, D., & Sarah, M. C. (2007). Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Rosenbloom, 45(3), 259–263.
12.
go back to reference Kim, S. H., Kim, H. J., Lee, S. I., & Jo, M. W. (2012). Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea. Quality of Life Research, 21(6), 1065–1073. CrossRef Kim, S. H., Kim, H. J., Lee, S. I., & Jo, M. W. (2012). Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea. Quality of Life Research, 21(6), 1065–1073. CrossRef
13.
go back to reference Cheng, M. J., Hourigan, C. S., & Smith, T. J. (2014). Adult acute myeloid leukemia long-term survivors. Journal of Leukemia (Los Angel), 2, 2. Cheng, M. J., Hourigan, C. S., & Smith, T. J. (2014). Adult acute myeloid leukemia long-term survivors. Journal of Leukemia (Los Angel), 2, 2.
14.
go back to reference van Dongen-Leunis, A., Redekop, W. K., & Uyl-de Groot, C. A. (2016). Which questionnaire should be used to measure quality-of-life utilities in patients with acute leukemia? An evaluation of the validity and interpretability of the EQ-5D-5L and preference-based questionnaires derived from the EORTC QLQ-C30. Value Health., 19(6), 834–843. CrossRef van Dongen-Leunis, A., Redekop, W. K., & Uyl-de Groot, C. A. (2016). Which questionnaire should be used to measure quality-of-life utilities in patients with acute leukemia? An evaluation of the validity and interpretability of the EQ-5D-5L and preference-based questionnaires derived from the EORTC QLQ-C30. Value Health., 19(6), 834–843. CrossRef
15.
go back to reference Liu, G. G., Wu, H., Li, M., Chen, G., & Nan, L. J. (2014). Chinese time trade-off values for EQ-5D health states. Value in Health, 17(5), 597–604. CrossRef Liu, G. G., Wu, H., Li, M., Chen, G., & Nan, L. J. (2014). Chinese time trade-off values for EQ-5D health states. Value in Health, 17(5), 597–604. CrossRef
16.
go back to reference Luo, N., Liu, G., Li, M., Guan, H., Jin, X., & Rand-Hendriksen, K. (2017 Apr). Estimating an EQ-5D-5L value set for China. Value Health, 20(4), 662–669. CrossRef Luo, N., Liu, G., Li, M., Guan, H., Jin, X., & Rand-Hendriksen, K. (2017 Apr). Estimating an EQ-5D-5L value set for China. Value Health, 20(4), 662–669. CrossRef
17.
go back to reference Fairclough, D. L., & Cella, D. F. (1996). Functional Assessment of Cancer Therapy (FACT-G): Non-response to individual questions. Quality of Life Research, 5(3), 321–329. CrossRef Fairclough, D. L., & Cella, D. F. (1996). Functional Assessment of Cancer Therapy (FACT-G): Non-response to individual questions. Quality of Life Research, 5(3), 321–329. CrossRef
18.
go back to reference Yu, C. L., Fielding, R., Chan, C. L., Tse, V. K., Choi, P. H., Lau, W. H., et al. (2015). Measuring quality of life of Chinese cancer patients: A validation of the Chinese version of the Functional Assessment of Cancer Therapy-General (FACT-G) scale. Multicenter Study, 88(7), 1715–1727. Yu, C. L., Fielding, R., Chan, C. L., Tse, V. K., Choi, P. H., Lau, W. H., et al. (2015). Measuring quality of life of Chinese cancer patients: A validation of the Chinese version of the Functional Assessment of Cancer Therapy-General (FACT-G) scale. Multicenter Study, 88(7), 1715–1727.
19.
go back to reference Wan, C., Meng, Q., Tang, X., Zhang, C., Luo, J., & Zhang, X. (2006). Validation of cancer patient quality of life measurement scale FACT-G Chinese version. Journal of Practical Oncology, 21(1), 77–80. Wan, C., Meng, Q., Tang, X., Zhang, C., Luo, J., & Zhang, X. (2006). Validation of cancer patient quality of life measurement scale FACT-G Chinese version. Journal of Practical Oncology, 21(1), 77–80.
20.
go back to reference Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361–370. CrossRef Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361–370. CrossRef
21.
go back to reference Marziliano, A., Pessin, H., Rosenfeld, B., & Breitbart, W. (2018). Measuring cohesion and self-disclosure in psychotherapy groups for patients with advanced cancer: An analysis of the psychometric properties of the group therapy experience scale. International Journal of Group Psychotherapy, 68(3), 407–427. CrossRef Marziliano, A., Pessin, H., Rosenfeld, B., & Breitbart, W. (2018). Measuring cohesion and self-disclosure in psychotherapy groups for patients with advanced cancer: An analysis of the psychometric properties of the group therapy experience scale. International Journal of Group Psychotherapy, 68(3), 407–427. CrossRef
22.
go back to reference Xiao, S. Y. (1994). The theoretical basis and research applications of “Social Support Rating Scale”. The Journal of Clinical Psychiatry, 4(2), 98–100. Xiao, S. Y. (1994). The theoretical basis and research applications of “Social Support Rating Scale”. The Journal of Clinical Psychiatry, 4(2), 98–100.
23.
go back to reference Li, L., Liu, C., Cai, X., Yu, H., Zeng, X., Sui, M., et al. (2019 May 30). Validity and reliability of the EQ-5D-5 L in family caregivers of leukemia patients. BMC Cancer, 19(1), 522. CrossRef Li, L., Liu, C., Cai, X., Yu, H., Zeng, X., Sui, M., et al. (2019 May 30). Validity and reliability of the EQ-5D-5 L in family caregivers of leukemia patients. BMC Cancer, 19(1), 522. CrossRef
25.
go back to reference Efficace, F., Rosti, G., Aaronson, N., Cottone, F., Angelucci, E., Molica, S., et al. (2014 Apr). Patient- versus physician-reporting of symptoms and health status in chronic myeloid leukemia. Haematologica, 99(4), 788–793. CrossRef Efficace, F., Rosti, G., Aaronson, N., Cottone, F., Angelucci, E., Molica, S., et al. (2014 Apr). Patient- versus physician-reporting of symptoms and health status in chronic myeloid leukemia. Haematologica, 99(4), 788–793. CrossRef
26.
go back to reference Terwee, C. B., Bot, S. D., de Boer, M. R., van der Windt, D. A., Knol, D. L., Dekker, J., et al. (2007 Jan). Quality criteria were proposed for measurement properties of health status questionnaires. Journal of Clinical Epidemiology, 60(1), 34–42. CrossRef Terwee, C. B., Bot, S. D., de Boer, M. R., van der Windt, D. A., Knol, D. L., Dekker, J., et al. (2007 Jan). Quality criteria were proposed for measurement properties of health status questionnaires. Journal of Clinical Epidemiology, 60(1), 34–42. CrossRef
27.
go back to reference Janssen, M. F., Birnie, E., Haagsma, J. A., & Bonsel, G. J. (2008). Comparing the standard EQ-5D three-level system with a five-level version. Value Health, 11(2), 275–284. CrossRef Janssen, M. F., Birnie, E., Haagsma, J. A., & Bonsel, G. J. (2008). Comparing the standard EQ-5D three-level system with a five-level version. Value Health, 11(2), 275–284. CrossRef
28.
go back to reference Cohen, J. (2013). Statistical power analysis for the behavioral sciences. London: Routledge. CrossRef Cohen, J. (2013). Statistical power analysis for the behavioral sciences. London: Routledge. CrossRef
29.
go back to reference Yfantopoulos, J. N., & Chantzaras, A. E. (2017 May). Validation and comparison of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in Greece. The European Journal of Health Economics, 18(4), 519–531. CrossRef Yfantopoulos, J. N., & Chantzaras, A. E. (2017 May). Validation and comparison of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in Greece. The European Journal of Health Economics, 18(4), 519–531. CrossRef
30.
go back to reference Janssen, M. F., Bonsel, G. J., & Luo, N. (2018 Jun). Is EQ-5D-5L better than EQ-5D-3L? A head-to-head comparison of descriptive systems and value sets from seven countries. Pharmacoeconomics., 36(6), 675–697. CrossRef Janssen, M. F., Bonsel, G. J., & Luo, N. (2018 Jun). Is EQ-5D-5L better than EQ-5D-3L? A head-to-head comparison of descriptive systems and value sets from seven countries. Pharmacoeconomics., 36(6), 675–697. CrossRef
31.
go back to reference Vickrey, B. G., Hays, R. D., Genovese, B. J., Myers, L. W., & Ellison, G. W. (1997). Comparison of a generic to disease-targeted health-related quality-of-life measures for multiple sclerosis. Journal of Clinical Epidemiology, 50(5), 557–569. CrossRef Vickrey, B. G., Hays, R. D., Genovese, B. J., Myers, L. W., & Ellison, G. W. (1997). Comparison of a generic to disease-targeted health-related quality-of-life measures for multiple sclerosis. Journal of Clinical Epidemiology, 50(5), 557–569. CrossRef
32.
go back to reference Pickard, A. S., Ray, S., Ganguli, A., & Cella, D. (2012). Comparison of FACT- and EQ-5D-based utility scores in cancer. Value Health, 15(2), 305–311. CrossRef Pickard, A. S., Ray, S., Ganguli, A., & Cella, D. (2012). Comparison of FACT- and EQ-5D-based utility scores in cancer. Value Health, 15(2), 305–311. CrossRef
33.
go back to reference Huang, I. C., Willke, R. J., Atkinson, M. J., Lenderking, W. R., Frangakis, C., & Wu, A. W. (2007). US and UK versions of the EQ-5D preference weights: does choice of preference weights make a difference? Quality of Life Research, 16(6), 1065–1072. CrossRef Huang, I. C., Willke, R. J., Atkinson, M. J., Lenderking, W. R., Frangakis, C., & Wu, A. W. (2007). US and UK versions of the EQ-5D preference weights: does choice of preference weights make a difference? Quality of Life Research, 16(6), 1065–1072. CrossRef
34.
go back to reference Hays, R. D., Anderson, R., & Revicki, D. (1993). Psychometric considerations in evaluating health-related quality of life measures. Quality of Life Research., 2(6), 441–449. CrossRef Hays, R. D., Anderson, R., & Revicki, D. (1993). Psychometric considerations in evaluating health-related quality of life measures. Quality of Life Research., 2(6), 441–449. CrossRef
35.
go back to reference Petrou, S., Morrell, J., & Spiby, H. (2009 May). Assessing the empirical validity of alternative multi-attribute utility measures in the maternity context. Health Qual Life Outcomes., 6(7), 40. CrossRef Petrou, S., Morrell, J., & Spiby, H. (2009 May). Assessing the empirical validity of alternative multi-attribute utility measures in the maternity context. Health Qual Life Outcomes., 6(7), 40. CrossRef
36.
go back to reference Petrou, S., & Hockley, C. (2005 Nov). An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population. Health Economics, 14(11), 1169–1189. CrossRef Petrou, S., & Hockley, C. (2005 Nov). An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population. Health Economics, 14(11), 1169–1189. CrossRef
37.
go back to reference Landis, J. R., & Koch, G. G. (1977). The measurement of observer agreement for categorical data. Biometrics, 33(1), 159–174. CrossRef Landis, J. R., & Koch, G. G. (1977). The measurement of observer agreement for categorical data. Biometrics, 33(1), 159–174. CrossRef
38.
go back to reference Rajmil LJJoE, Health C. Health measurement scales. A practical guide to their development and use, 3rd ed. 2015;47(5):484.e1-.e1. Rajmil LJJoE, Health C. Health measurement scales. A practical guide to their development and use, 3rd ed. 2015;47(5):484.e1-.e1.
39.
go back to reference Schwenkglenks, M., & Matter-Walstra, K. (2016). Is the EQ-5D suitable for use in oncology? An overview of the literature and recent developments. Expert Review of Pharmacoeconomics & Outcomes Research, 16(2), 207–219. CrossRef Schwenkglenks, M., & Matter-Walstra, K. (2016). Is the EQ-5D suitable for use in oncology? An overview of the literature and recent developments. Expert Review of Pharmacoeconomics & Outcomes Research, 16(2), 207–219. CrossRef
40.
go back to reference Lang, H. C., Chuang, L., Shun, S. C., Hsieh, C. L., & Lan, C.-F. (2010). Validation of EQ-5D in patients with cervical cancer in Taiwan. Supportive Care in Cancer, 18(10), 1279–1286. CrossRef Lang, H. C., Chuang, L., Shun, S. C., Hsieh, C. L., & Lan, C.-F. (2010). Validation of EQ-5D in patients with cervical cancer in Taiwan. Supportive Care in Cancer, 18(10), 1279–1286. CrossRef
41.
go back to reference Janssen, M. F., Pickard, A. S., Golicki, D., Gudex, C., Niewada, M., Scalone, L., et al. (2013 Sep). Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Quality of Life Research, 22(7), 1717–1727. CrossRef Janssen, M. F., Pickard, A. S., Golicki, D., Gudex, C., Niewada, M., Scalone, L., et al. (2013 Sep). Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Quality of Life Research, 22(7), 1717–1727. CrossRef
Metagegevens
Titel
A head-to-head comparison of measurement properties of the EQ-5D-3L and EQ-5D-5L in acute myeloid leukemia patients
Auteurs
Hongjuan Yu
Xueyun Zeng
Mingjie Sui
Rui Liu
Rachel Lee-Yin Tan
Jinjin Yang
Weidong Huang
Nan Luo
Publicatiedatum
23-09-2020
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 3/2021
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-020-02644-w